Stockreport

Rapport Therapeutics to Participate in Upcoming Investor Conferences

Rapport Therapeutics, Inc.  (RAPP) 
PDF BOSTON and SAN DIEGO, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Rapport Therapeutics, Inc. (Nasdaq: RAPP) (“Rapport” or the “Company”), a clinical-stage biotechnology company [Read more]